Demannose

Demannose

SCHEMBL1703216

CON.O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TDP1 Q9NUW8 1/20 0.42
USP2 O75604 1/20 0.39
SLCO1B1 Q9Y6L6 1/20 0.39
KDM4E B2RXH2 2/20 0.38
PDE4A P27815 1/20 0.38
AKR1B1 P15121 1/20 0.34
MPI P34949 1/20 0.33
TOP1 P11387 1/20 0.32
PAX8 Q06710 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Demannose SCHEMBL1703512 1.00 LMNA (0.44) LMNAL3MBTL1TDP1USP2SLCO1B1
Demannose SCHEMBL27881671 1.00 LMNA (0.44) LMNAL3MBTL1TDP1USP2SLCO1B1
Galactose SCHEMBL1704081 1.00 LMNA (0.44) LMNAL3MBTL1TDP1USP2SLCO1B1
Xylose SCHEMBL1703958 0.94 LMNA (0.40) LMNAL3MBTL1TDP1USP2SLCO1B1
Xylose SCHEMBL1703902 0.94 LMNA (0.40) LMNAL3MBTL1TDP1USP2SLCO1B1
Xylose SCHEMBL1703909 0.94 LMNA (0.40) LMNAL3MBTL1TDP1USP2SLCO1B1
Demannose SCHEMBL127458 0.92 LMNA (0.48) LMNAL3MBTL1TDP1USP2SLCO1B1
Demannose SCHEMBL3240842 0.90 LMNA (0.50) LMNAL3MBTL1TDP1USP2SLCO1B1
Demannose SCHEMBL27395259 0.90 LMNA (0.50) LMNAL3MBTL1TDP1USP2SLCO1B1
Demannose SCHEMBL8835653 0.87 LMNA (0.52) LMNAL3MBTL1TDP1USP2SLCO1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1695088-B1 METHOD FOR ANALYSING METABOLITES MAX PLANCK GESELLSCHAFT (DE) 2012-04-18 EP disclosed
US-20070141712-A1 Method for analysing metabolites MAX-PLANCK-GESSELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2007-06-21 US disclosed
EP-1695088-A1 METHOD FOR ANALYSING METABOLITES Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2006-08-30 EP disclosed
WO-2005059556-A1 METHOD FOR ANALYSING METABOLITES MAX PLANCK GESELLLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. (DE) 2005-06-30 WO disclosed